BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 25, 2018
View Archived Issues
Metabolic remodeling seen during liver regeneration
Read More
New Tau tracer [18F]S16 distinguishes patients with Alzheimer's disease from healthy controls
Read More
Long noncoding RNA CALM3-AS1 acts as a microRNA sponge to promote bladder cancer progression
Read More
Metastasis and self-renewal of group 3 medulloblastomas is driven by NOTCH1
Read More
DeltaNp63 promotes metastasis in triple-negative breast cancer
Read More
Exome sequencing reveals SLC20A1 to be a possible cause of cloacal and bladder exstrophy
Read More
Familial association of a variant in MEGF6 with osteoporosis
Read More
MDM2/p53 inhibitor PM-2 can radiosensitize p53-expressing tumors
Read More
AQP9 emerges as a candidate gene for keloid development
Read More
Results from the phase IIb RISE-SSc study of riociguat presented
Read More
Oyster Point's OC-01 and OC-02 demonstrate improvement in Schirmer's score for dry eye disease
Read More
China NMPA accepts NDA for zanubrutinib in relapsed/refractory CLL/SLL
Read More
Phase IIb study of SM-04690 in knee osteoarthritis meets primary endpoints
Read More
Takeda Pharmaceutical identifies GPR6 receptor modulators
Read More
Roche and Genentech patent new MAP4K1 inhibitors
Read More
Alexion and Dicerna collaborate on RNAi therapies for complement-mediated diseases
Read More
Inventiva synthesizes YAP-TEAD interaction inhibitors
Read More
Kyoto Pharmaceutical Industries divulges nonsense mutation suppressors
Read More
Janssen and collaborator present new antiviral compounds
Read More
Pfizer opens phase I study of PF-06952229 for advanced solid tumors
Read More
Syntrix enrolling patients for phase II trial of Omnitram for diabetic neuropathy
Read More
Privo opens phase I/II trial of PRV-111 for early-stage oral cancer
Read More
FDA approves Xofluza for influenza
Read More
First patient dosed in study of AXO-Lenti-PD gene therapy for Parkinson's disease
Read More
Growth hormone deficiency caused by homozygous GH1 deletion
Read More
Whole exome sequencing of Tunisian patients with ataxia further expands the known causative genes
Read More
Confirmatory phase III study of Talicia for H. pylori infection completes final patient assessment
Read More